A phase III, double-blind, non-inferiority, randomized controlled trial of antiemetic prophylaxis for highly emetogenic chemotherapy without dexamethasone: CINV POD study

被引：0
|
作者：
Radhakrishnan, Venkatraman [1 ]
Venkatakrishnan, Kritthivasan [1 ]
Kalaiyarasi, Jayachandran Perumal [1 ]
Selvarajan, Gangothri [1 ]
Mahaboobasha, Nizamudin [1 ]
Victor, Paulson Vijaykumar [1 ]
Anbazhagan, Malarvizhi [1 ]
Sivanandam, Deyva Manohari [1 ]
Rajaraman, Swaminathan [1 ]
机构：
[1] Canc Inst WIA, Chennai, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12127
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial
    Bakhshi, Sameer
    Batra, Atul
    Biswas, Bivas
    Dhawan, Deepa
    Paul, Reeja
    Sreenivas, Vishnubhatla
    SUPPORTIVE CARE IN CANCER, 2015, 23 (11) : 3229 - 3237
  • [32] Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial
    Sameer Bakhshi
    Atul Batra
    Bivas Biswas
    Deepa Dhawan
    Reeja Paul
    Vishnubhatla Sreenivas
    Supportive Care in Cancer, 2015, 23 : 3229 - 3237
  • [33] MILDRONATE VERSUS LEVOCARNITINE IN PATIENTS WITH ISCHEMIC HEART DISEASE: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, NON-INFERIORITY TRIAL
    Shu, M. Q.
    Song, Z. Y.
    Jing, T.
    Zhang, Q.
    Song, Y. M.
    Zhang, Y.
    Yang, C. M.
    Zhang, H.
    Yin, Y. H.
    Liu, D.
    Hao, Y. M.
    Liu, F.
    Zheng, Q.
    Xiao, J. F.
    Li, X. T.
    Fu, H.
    Chen, Y.
    She, B. R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 2 - 2
  • [34] Efficacy and safety of fosaprepitant in the prevention of nausea and vomiting following highly emetogenic chemotherapy in Chinese people: A randomized, double-blind, phase III study
    Yang, L. Q.
    Sun, X. C.
    Qin, S. K.
    Cheng, Y.
    Shi, J. H.
    Chen, Z. D.
    Wang, Q. M.
    Zhang, H. L.
    Hu, B.
    Liu, B.
    Zhang, Q. Y.
    Wu, Q.
    Wang, D.
    Shu, Y. Q.
    Dong, J.
    Han, B. H.
    Wang, K. M.
    Dang, C. X.
    Li, J. L.
    Wang, H. B.
    Li, B. L.
    Lu, J. G.
    Zhang, Z. H.
    Chen, Y. X.
    EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (06)
  • [35] Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE
    Hata, Akito
    Okamoto, Isamu
    Inui, Naoki
    Okada, Morihito
    Morise, Masahiro
    Akiyoshi, Kohei
    Takeda, Masayuki
    Watanabe, Yasutaka
    Sugawara, Shunichi
    Shinagawa, Naofumi
    Kubota, Kaoru
    Saeki, Toshiaki
    Tamura, Tomohide
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (02) : 180 - +
  • [36] Transdermal granisetron for the prevention of nausea and vomiting following moderately or highly emetogenic chemotherapy in Chinese patients: a randomized, double-blind, phase III study
    Yang, Liu-Qing
    Sun, Xin-Chen
    Qin, Shu-Kui
    Chen, Ying-Xia
    Zhang, He-Long
    Cheng, Ying
    Chen, Zhen-Dong
    Shi, Jian-Hua
    Wu, Qiong
    Bai, Yu-Xian
    Han, Bao-Hui
    Liu, Wei
    Ouyang, Xue-Nong
    Liu, Ji-Wei
    Zhang, Zhi-Hui
    Li, Yong-Qiang
    Xu, Jian-Ming
    Yu, Shi-Ying
    CHINESE CLINICAL ONCOLOGY, 2016, 5 (06)
  • [37] Efficacy of Thalidomide in Preventing Delayed Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase III Trial (CLOG1302 study)
    Zhang, Lingyun
    Qu, Xiujuan
    Teng, Yuee
    Shi, Jing
    Yu, Ping
    Sun, Tao
    Wang, Jingyan
    Zhu, Zhitu
    Zhang, Xiuna
    Zhao, Mingfang
    Liu, Jing
    Jin, Bo
    Luo, Ying
    Teng, Zan
    Dong, Yuyang
    Wen, Fugang
    An, Yuzhi
    Yuan, Caijun
    Chen, Tiejun
    Zhou, Lizhong
    Chen, Ying
    Zhang, Jian
    Wang, Zhenghua
    Qu, Jinglei
    Jin, Feng
    Zhang, Jingdong
    Jin, Xiuhua
    Xie, Xiaodong
    Wang, Jun
    Man, Li
    Fu, Lingyu
    Liu, Yunpeng
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (31) : 3558 - +
  • [38] Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: a randomised, phase 3, double-blind, double-dummy, non-inferiority study
    Kovacs, Gabor
    Wachtel, Antonio E.
    Basharova, Elena V.
    Spinelli, Tulla
    Nicolas, Pierre
    Kabickova, Edita
    LANCET ONCOLOGY, 2016, 17 (03): : 332 - 344
  • [39] Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study
    Suzuki, K.
    Yamanaka, T.
    Hashimoto, H.
    Shimada, Y.
    Arata, K.
    Matsui, R.
    Goto, K.
    Takiguchi, T.
    Ohyanagi, F.
    Kogure, Y.
    Nogami, N.
    Nakao, M.
    Takeda, K.
    Azuma, K.
    Nagase, S.
    Hayashi, T.
    Fujiwara, K.
    Shimada, T.
    Seki, N.
    Yamamoto, N.
    ANNALS OF ONCOLOGY, 2016, 27 (08) : 1601 - 1606
  • [40] Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout”
    Kevin D. B. van Leeuwen
    Arthur M. Bohnen
    Rheumatology and Therapy, 2020, 7 : 215 - 216
12345